Prostate Cancer: Regional Insight and Multidisciplinary Excellence
Type
Webinaire
DÉTAILS DE L’ACTIVITÉ
Display Date
Monday December 9th, 2024
Display Date Line 2
20:00 ET
Speaker
Michael Chang, Kim Chi & Michael Ong
CRÉDITS
Accreditation
Section 1 Group Learning Credits
Event Description
Speakers: Michael Chang, Kim Chi & Michael Ong
Objectives
By participating in this learning program, healthcare providers can expect to gain an understanding of:
- Understand the latest testing and treatment considerations for advanced prostate cancer (PCa) patients with genetic mutations, including those with HRR and MMR mutations.
- Navigate complex advanced PCa cases across diverse healthcare settings.
- Leverage multi-disciplinary insights on effective adverse event management.
- Formulate strategies to optimize multidisciplinary patient care plans.
Footer
ACCREDITATION
This activity is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by CUA. You may claim a maximum of 1 hour of credit.
________________________
Sponsor:
